Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary G Kay

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Human Psychopharmacology|October 31, 2002
Functional magnetic resonance imaging reflects changes in brain functioning with sedationVictoria N Starbuck, Gary G Kay, R. Craig Platenberg, et al.
Postgraduate Medicine|June 14, 2012
Evaluation of cognitive function in healthy older subjects treated with fesoterodineGary G Kay, Paul Maruff, David Scholfield, et al.
Journal of Sleep Research|June 21, 2021
Simulated driving performance in healthy adults after night-time administration of 20 mg tasimelteonRosarelis Torres, Michaela Fisher, Gunther Birznieks, et al.
Drugs & Aging|March 7, 2012
Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladderMichael B Chancellor, David R Staskin, Gary G Kay, et al.
Journal of the American Geriatrics Society|January 10, 2006
Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patientsGary G Kay, Mohamed B Abou-Donia, William S Messer, et al.
Human Psychopharmacology|May 26, 2020
Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controlsEric M Pearlman, Darren Wilbraham, Ellen B Dennehy, et al.
British Journal of Clinical Pharmacology|March 12, 2011
A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladderErnesto Callegari, Bimal Malhotra, Peter J Bungay, et al.
The American Psychologist|March 20, 2002
Amplifying issues related to psychological testing and assessmentGregory J Meyer, Stephen E Finn, Lorraine D Eyde, et al.
Therapeutic Advances in Drug Safety|August 5, 2015
A randomized, crossover, placebo-controlled clinical trial to assess the sensitivity of the CRCDS Mini-Sim to the next-day residual effects of zopicloneArthur A Simen, Cynthia Gargano, Jang-Ho Cha, et al.
Journal of Clinical Pharmacology|October 15, 2013
Early-stage comparative effectiveness: randomized controlled trial with histamine inverse agonist MK-7288 in excessive daytime sleepiness patientsHong Sun, Catherine MacLeod, Kate Mostoller, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Human Psychopharmacology|October 31, 2002
Functional magnetic resonance imaging reflects changes in brain functioning with sedationVictoria N Starbuck, Gary G Kay, R. Craig Platenberg, et al.
Postgraduate Medicine|June 14, 2012
Evaluation of cognitive function in healthy older subjects treated with fesoterodineGary G Kay, Paul Maruff, David Scholfield, et al.
Journal of Sleep Research|June 21, 2021
Simulated driving performance in healthy adults after night-time administration of 20 mg tasimelteonRosarelis Torres, Michaela Fisher, Gunther Birznieks, et al.
Drugs & Aging|March 7, 2012
Blood-brain barrier permeation and efflux exclusion of anticholinergics used in the treatment of overactive bladderMichael B Chancellor, David R Staskin, Gary G Kay, et al.
Journal of the American Geriatrics Society|January 10, 2006
Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patientsGary G Kay, Mohamed B Abou-Donia, William S Messer, et al.
Human Psychopharmacology|May 26, 2020
Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controlsEric M Pearlman, Darren Wilbraham, Ellen B Dennehy, et al.
British Journal of Clinical Pharmacology|March 12, 2011
A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladderErnesto Callegari, Bimal Malhotra, Peter J Bungay, et al.
The American Psychologist|March 20, 2002
Amplifying issues related to psychological testing and assessmentGregory J Meyer, Stephen E Finn, Lorraine D Eyde, et al.
Therapeutic Advances in Drug Safety|August 5, 2015
A randomized, crossover, placebo-controlled clinical trial to assess the sensitivity of the CRCDS Mini-Sim to the next-day residual effects of zopicloneArthur A Simen, Cynthia Gargano, Jang-Ho Cha, et al.
Journal of Clinical Pharmacology|October 15, 2013
Early-stage comparative effectiveness: randomized controlled trial with histamine inverse agonist MK-7288 in excessive daytime sleepiness patientsHong Sun, Catherine MacLeod, Kate Mostoller, et al.
Pageof 3